Web version

 

 
PRECISION
HEALTH

“Theranostics using gallium-68 and lutetium-177 is a very promising patient management strategy in precision medicine.”
 
Dr. Irene Burger, University Hospital Zurich, Switzerland
 
Health care providers are striving to deliver more personalized medicine to patients. Theranostics is writing a new chapter in Precision Health by combining precision diagnostics and targeted therapeutics.
 
GE Healthcare represents a unique Molecular Imaging partner to help you deploy a theranostics program in your institution.
 

 
Dr. Irene Burger, University Hospital Zurich, Switzerland
 
WATCH VIDEO
 
 
GE Healthcare helps you make theranostics a reality for neuroendocrine tumors and prostate cancer by offering:
 

ACCESS TO TUMOR-SPECIFIC TRACERS
 
Cyclotron in-target gallium-68 production gives you access to a variety of tracers for tumor-specific imaging.
 

PRECISION DIAGNOSTIC SOLUTIONS
 
Targeted PET imaging using tumor-specific radiotracer enables more accurate diagnosis and (re)staging to help choose a personalized treatment strategy.
 
GE’s latest PET technology improves detectability of small lesions and quantitation accuracy by increasing sensitivity, reducing noise and managing respiratory motion.
 

PRECISION THERAPEUTIC MONITORING SOLUTIONS
 
Combination of digital SPECT/CT and quantitation allows a more accurate implementation of nuclear therapies.
 
Dosimetry applications help quantify dose limits per individual patient, monitor tumor response and follow-up organ toxicity during treatment.
 
MORE INFORMATION ABOUT MOLECULAR IMAGING
 
 
 
                                                           
 
 Do not reply to this email as it was sent from an unmonitored account.
  
Unsubscribe from the Breaking News.
  
Reset your password.
  
Contact auntminnieeurope.com support.
  
AuntMinnieEurope.com Privacy Policy
  
Email sent to: .
 

AuntMinnieEurope.com, 1350 North Kolb Road, Suite 215, Tucson, AZ 85715 USA
+1 520-298-1000